Navigation Links
Obio Pharmaceutical Announces Product Growth Strategy
Date:2/18/2009

the company growth and could then further reinvest in the drug discovery process."

Mr. K C Cheng, Director and Chief Financial Officer said, "Obio's board is satisfied with the current development and strives to achieve the Company's mission by putting the company onto a listed company platform as soon as possible and continues to research, develop and commercialize novel medicines for the underserved diseases affecting millions of patients worldwide."

About Obio Pharmaceutical Holdings Limited

Obio is a Hong Kong-based international pharmaceutical company. Obio targets to research, develop and commercialize novel medicines for the underserved diseases affecting millions of patients worldwide. Obio is a knowledge-based, technology driven pharmaceutical company, dedicated to the research and development of novel drugs, and bringing them into the market through co-development with other prestigious pharmaceutical companies. Obio's research center is located at Beijing and researches are often contracted to outside prestigious medical institutes for confirmation of experiment data. Details please refer to http://www.obiopharma.com .

    For more information, please contact:

     JOVIAN Financial Communications Ltd
     Angel Y Y Yeung / Alice Choi
     Tel   +852-2154-7810
     Fax:   +852-2854-2012
     Email: alice.choi@joviancomm.com / angel.yeung@joviancomm.com

'/>"/>
SOURCE Obio Pharmaceutical Holdings Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009
2. Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
3. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
4. TechniKroms Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical
5. Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009
6. Vion Pharmaceuticals Submits New Drug Application for Onrigin(TM)
7. Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
8. Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
9. XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
10. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
11. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... (PRWEB) November 27, 2014 Spartan Bioscience ... of Food and Drug Safety (MFDS) regulatory approval for ... provides genetic results in less than 60 minutes from ... indicated as an aid for doctors to determine therapeutic ... pathway. These include some of the world’s most commonly ...
(Date:11/27/2014)... -- Calcivis, a medical devices company ... today announces that it has completed a first ... System. The Calcivis Caries Activity Imaging ... combination designed to transform the assessment and management ... unique, proprietary bioluminescence approach combined with a specialised ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Publicis Healthcare ... today announced the organization has won a total of ... Digitas Health LifeBrands was honored with a Silver Award ... agencies received eight Awards of Excellence. , The ... pharmaceutical advertising and promotion. The Awards provide a forum ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... Bifluoride Industry” is a professional and in-depth research ... Ammonium Bifluoride information, like its definition, classification, application, ... overview. This report covers the international market analysis, ... (such as the US, Europe, Asia, China, Japan ...
Breaking Biology Technology:Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3Publicis Healthcare Wins 20 Rx Club Awards 2Publicis Healthcare Wins 20 Rx Club Awards 3Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3
... (Nasdaq: MNKD ), focused on discovering, developing and,commercializing ... present at the UBS Global Life Sciences Conference on ... Hyatt Hotel in New York, NY. Interested parties ... of the,presentation in the Investor Relations section of the ...
... Sept. 18 InterMune, Inc.,(Nasdaq: ITMN ) today ... other conditions, 3,000,000 shares of its common stock in ... underwriters,a 30-day option to purchase up to an additional ... All of the shares in the offering,will be sold ...
... Sept. 18 /PRNewswire-FirstCall/-- Biodel Inc. (Nasdaq:,BIOD) today ... program,at the 43rd Scientific Sessions of the ... VIAject(TM) Phase II meal study data ... entitled, "Pharmacokinetics and pharmacodynamics of,insulin VIAject(TM), insulin ...
Cached Biology Technology:InterMune Announces Proposed Public Offering of Common Stock 2Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 2Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 3
(Date:11/6/2014)... occur because of metastasis, yet progress in preventing ... , "It,s been particularly challenging to design drugs ... fellow in systems biology at Harvard Medical School. ... after they,ve already metastasized." , Gujral and colleagues ... help researchers better understand how metastasis begins. Their ...
(Date:11/5/2014)... his career to understanding the Earth,s climate and ... As deputy director and regional climatologist for the ... Institute, Redmond has more than three decades of ... climate data to the general public. , At ... on December 15-19, 2014 the American Geophysical Union ...
(Date:11/4/2014)... – Temple University School of Medicine announced today ... an initiative funded by the Bill & Melinda ... of Obstetrics, Gynecology and Reproductive Sciences; and Vice ... University School of Medicine will pursue an innovative ... Blood Biomarkers to Assess Fetal Neurodevelopment.", Grand Challenges ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2Temple University School of Medicine receives Grand Challenges Explorations grant 2
... Renal diseases shall be diagnosed earlier and treated more ... nine European countries*, coordinated by the Max Delbrck Center ... for the past four-and-a half years to create a ... findings on the development and diseases of the kidney. ...
... Stress may indeed be a direct contributor to childhood ... study finding that increased levels of stress in adolescents ... overweight or obese. The study of 1,011 adolescents ... living in three cities -- Boston, Chicago and San ...
... - A new article published in Elsevier,s journal Bioscience ... our lifetime can affect our children. Dr. Halabe Bucay ... generates when we are in different moods could affect ,germ ... next generation. Such natural chemicals could affect the way that ...
Cached Biology News:3-D kidney atlas created for researchers and physicians 2Study finds link between individual stress and adolescent obesity 2Study finds link between individual stress and adolescent obesity 3
... laser scanners is the starting point of ... ,Gene expression analysis, SNP (Single Nucleotide Polymorphism) ... the advancement of research in the post-genomics ... formats and sizes. These arrays call for ...
...
Cell Culture Flask, 25 cm, tissue-culture treated polystyrene...
... Disposable. Virgin, optically clear polystyrene with ... alphanumeric coordinates for cell counting. 100% ... is a new product number, created ... If showing no availability yet, please ...
Biology Products: